Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.
Circulating tumor cells (CTCs) have been proposed to be an active source of metastasis or recurrence of hepatocellular carcinoma (HCC). The enumeration and characterization of CTCs has important clinical significance in recurrence prediction and treatment monitoring in HCC patients. We previously developed a unique method to separate HCC CTCs based on the interaction of the asialoglycoprotein receptor (ASGPR) expressed on their membranes with its ligand. The current study applied the ligand-receptor binding assay to a CTC-chip in a microfluidic device. Efficient capture of HCC CTCs originates from the small dimensions of microfluidic channels and enhanced local topographic interactions between the microfluidic channel and extracellular extensions. With the optimized conditions, a capture yield reached > 85% for artificial CTC blood samples. Clinical utility of the system was further validated. CTCs were detected in all the examined 36 patients with HCC, with an average of 14 ± 10/2 mL. On the contrary, no CTCs were detected in healthy, benign liver disease or non-HCC cancer subjects. The current study also successfully demonstrated that the captured CTCs on our CTC-chip were readily released with ethylene diamine tetraacetic acid (EDTA); released CTCs remained alive and could be expanded to form a spheroid-like structure in a 3-dimensional cell culture assay; furthermore, sensitivity of released CTCs to chemotherapeutic agents (sorafenib or oxaliplatin) could be effectively tested utilizing this culture assay. In conclusion, the methodologies presented here offer great promise for accurate enumeration and easy release of captured CTCs, and released CTCs could be cultured for further functional studies.
a Molecular Oncology Laboratory , Eastern Hepatobiliary Surgery Hospital, Second Military Medical University , Shanghai , P.R. China.
Yu
Y
Zhang
a Molecular Oncology Laboratory , Eastern Hepatobiliary Surgery Hospital, Second Military Medical University , Shanghai , P.R. China.
Xiaofeng
X
Zhang
b Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3), Department of Environmental Science & Engineering , Institute of Biomedical Science, Fudan University , Shanghai , P.R. China.
Jinling
J
Zhang
a Molecular Oncology Laboratory , Eastern Hepatobiliary Surgery Hospital, Second Military Medical University , Shanghai , P.R. China.
Bin
B
Sun
b Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3), Department of Environmental Science & Engineering , Institute of Biomedical Science, Fudan University , Shanghai , P.R. China.
Lulu
L
Zheng
a Molecular Oncology Laboratory , Eastern Hepatobiliary Surgery Hospital, Second Military Medical University , Shanghai , P.R. China.
Jun
J
Li
b Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3), Department of Environmental Science & Engineering , Institute of Biomedical Science, Fudan University , Shanghai , P.R. China.
Sixiu
S
Liu
b Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3), Department of Environmental Science & Engineering , Institute of Biomedical Science, Fudan University , Shanghai , P.R. China.
Guodong
G
Sui
a Molecular Oncology Laboratory , Eastern Hepatobiliary Surgery Hospital, Second Military Medical University , Shanghai , P.R. China.
Zhengfeng
Z
Yin
D000072283:A549 Cells; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor; D005434:Flow Cytometry; D056945:Hep G2 Cells; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D061986:MCF-7 Cells; D044085:Microfluidics; D009360:Neoplastic Cells, Circulating / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D018874:Spheroids, Cellular; D014407:Tumor Cells, Cultured
Circulating tumor cells; culture; drug evaluation; hepatocellular carcinoma; ligand-receptor recognition; microfluidics
Oncotarget. 2016 Jan 19;7(3):2646-59
26544731
Diabetes Technol Ther. 2011 Jul;13(7):743-51
21510766
Hepatology. 2011 Mar;53(3):1020-2
21374666
World J Gastroenterol. 2015 Jun 7;21(21):6518-25
26074690
Lab Chip. 2013 Feb 21;13(4):602-9
23306378
World J Gastroenterol. 2015 Mar 14;21(10):2918-25
25780289
World J Gastroenterol. 2015 Apr 7;21(13):3970-7
25852283
Tumour Biol. 2014 Sep;35(9):8451-9
25038916
Expert Rev Anticancer Ther. 2016;16(2):169-75
26588992
Assay Drug Dev Technol. 2013 Sep;11(7):435-48
25310845
Br J Cancer. 2011 Sep 6;105(6):847-53
21829190
Oncotarget. 2014 Dec 15;5(23):12383-97
25474037
Expert Rev Mol Diagn. 2016;16(2):147-64
26587751
Acc Chem Res. 2014 Oct 21;47(10):2941-50
25111636
J Pathol. 1999 Jun;188(2):201-6
10398165
Cancers (Basel). 2014 Feb 07;6(1):323-32
24514165
Small. 2015 Aug 26;11(32):3850-72
25993898
Science. 2000 Apr 7;288(5463):113-6
10753110
J Hepatol. 2012 Aug;57(2):399-420
22633836
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18392-7
20930119
Cancer Res. 2010 Aug 15;70(16):6420-6
20663903
Clin Cancer Res. 2011 Jun 1;17(11):3783-93
21527564
Hum Pathol. 2004 Jan;35(1):122-8
14745734
J Cancer Res Clin Oncol. 2015 Feb;141(2):189-201
24965746
PLoS One. 2014 Apr 24;9(4):e96185
24763545
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3970-5
19234122
Electrophoresis. 2003 Nov;24(21):3563-76
14613181
World J Gastroenterol. 2015 Jul 28;21(28):8478-91
26229392
Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):353-67
19673623
Nature. 2007 Dec 20;450(7173):1235-9
18097410
World J Gastroenterol. 2014 Jan 7;20(1):142-7
24415867
Mod Pathol. 2000 Jul;13(7):773-8
10912937
Sci Rep. 2014 Dec 16;4:7499
25511131
Lancet Oncol. 2009 Jan;10(1):35-43
19058754
Int J Oncol. 2012 Oct;41(4):1241-50
22825490
Science. 2014 Jul 11;345(6193):216-20
25013076
World J Gastroenterol. 2015 Nov 14;21(42):12003-21
26576088
Clin Liver Dis. 2015 May;19(2):381-99
25921669
Int J Cancer. 2012 Apr 1;130(7):1590-7
21469140
Biotechnol Adv. 2013 Nov 15;31(7):1063-84
23999357
Analyst. 2016 Jan 21;141(2):382-92
26588824
Nat Rev Clin Oncol. 2015 Jul;12(7):408-24
26054909
Appl Immunohistochem Mol Morphol. 2000 Jun;8(2):120-5
10937059
Ann Surg. 2011 Mar;253(3):453-69
21263310
J Biochem Biophys Methods. 2005 Sep 30;64(3):207-15
16182371
J Clin Oncol. 2013 Oct 1;31(28):3501-8
23980077
Semin Oncol. 2012 Aug;39(4):449-60
22846862
Future Oncol. 2015;11(21):2923-36
26414336
Science. 2000 Nov 24;290(5496):1536-40
11090344